baber/WOPTO huggingface dataset:
Patent EP-3195466-A2 (EP)
Inventor: DUGUEY JEAN-FRANÇOIS
IPC: H02P25/022
Filed: 2015-07-31
Abstract: The present invention relates to a method for controlling an inverter device having six branches supplying power to a double three-phase machine (3) comprising three first windings (R, S, T) and three second windings (U, V, W), one first winding (R, S, T) being respectively adjacent to a second winding (U, V, W), the method comprising the following steps: - the commands to be applied to the branches of the inverter device are determined as a function of the desired operating point for the machine (3) by a pulse width modulation in which the pulses applied to the different branches are centred relative to one another, - from the determined commands, the commands for allowing at least one branch (B1, B2, B3, B4, B4, B5, B6) to be blocked are determined by varying, proportional to the pulse widths, the commands associated with the three first windings (R, S, T) and to the three second windings (U, V, W), - selecting the combinations of commands allowing two adjacent branches to be blocked, - and applying one of the selected combinations.
Patent EP-3171855-A2 (EP)
Title: Composés hydroxystéroïdes, leurs intermédiaires, procédé de préparation, composition et utilisations de ceux-ci
Inventor: DUGAR SUNDEEP
IPC: C12P33/08
Filed: 2015-07-23
Abstract: La présente invention concerne de nouveaux composés stéroïdiens de formule (I), un procédé de préparation de ceux-ci et une composition comprenant ces composés.
Patent EP-3098057-A2 (EP)
Inventor: HUMELE HEINZ
IPC: B29C35/08
Filed: 2007-05-10
Abstract: Die Erfindung betrifft ein Verfahren und eine Vorrichtung zum Erwärmen von Vorformlingen (1) aus einem thermoplastischen Material, wobei die Vorformlinge (1) nach ihrer Erwärmung einem Umformvorgang unterzogen werden und wobei die Vorformlinge (1) zumindest während eines Teils der zeitlichen Dauer der Erwärmung in einem Resonator (11) mit Mikrowellen beaufschlagt werden.
Patent EP-3100830-A2 (EP)
Inventor: SHIMODAIRA YASUHIRO
IPC: B25J9/16
Filed: 2016-05-31
Abstract: A robot (1) includes an arm (A) that has a plurality of arm members (A1-A6), a drive unit (M1-M6) driving the plurality of arm members (A1-A6) , and a grasp unit; and a force detector (FS) . The robot (1) sequentially performs a contact operation in which a fitting member (W) grasped by the grasp unit is moved in a predetermined contact direction and is brought into contact with a to-be-fitted member (Q), a posture change operation in which a posture of the fitting member (W) is changed to a fitting posture, and a fitting operation in which the fitting member (W) in the fitting posture is moved in a searching direction and the fitting member (W) is fitted into the to-be-fitted member (Q) in a fitting direction. The contact direction, the searching direction, and the fitting direction are directions different from one another.
Patent EP-3145026-A2 (EP)
Inventor: COLE DOUGLAS JOHN
IPC: H01Q3/20
Filed: 2016-08-24
Abstract: A method of operating a microwave antenna system that includes a microwave antenna, the method comprising operating the microwave antenna in a first operating state during an alignment operation for the microwave antenna system where the microwave antenna is configured to have a first beam width; and operating the microwave antenna subsequent to the alignment operation in a second operating state where the microwave antenna is configured to have a second beam width that is narrower than the first beam width.
Patent EP-3270946-A2 (EP)
Title: Agents thérapeutiques modifiés et compositions associées
Inventor: SHEN WEIJUN
IPC: A61K38/17
Filed: 2016-03-17
Abstract: L'invention concerne des méthodes et des compositions qui permettent de prolonger la demi-vie d'un agent thérapeutique. Un ou plusieurs fragments prolongeant la demi-vie peuvent être attachés à un agent thérapeutique, prolongeant de cette façon la demi-vie de l'agent thérapeutique. Les agents thérapeutiques modifiés comprenant un ou plusieurs fragments prolongeant la demi-vie attachés à un agent thérapeutique peuvent être utilisés pour traiter une maladie ou un état chez un patient nécessitant un tel traitement.
Patent EP-3482383-A2 (EP)
Title: Systèmes et procédés de mise en oeuvre d'un transport multimodal
Inventor: KUMAR ASHISH ANDREW
IPC: G08G1/123
Filed: 2017-07-07
Abstract: Des systèmes, un appareil et des procédés permettant de mettre en œuvre un transport multimodal transforment des objectifs de transport généralisés pour un segment d'un trajet d'une origine à une destination (par exemple, comme spécifié par un voyageur ou un expéditeur) en demandes de transport généralisées et spécifiques à diverses sources/fournisseurs de services de transport (par exemple des opérateurs, des plates-formes et des places de marché) sur différents modes de transport. Dans un exemple, des itinéraires généralisés et spécifiques reçus de diverses sources/fournisseurs de services de transport sont gérés pour satisfaire aux objectifs, et sont demandés de manière itérative au cours du temps, jusqu'au jour du transport, afin de rechercher des améliorations en ce qui concerne le respect des objectifs de transport. Dans un autre exemple, la surveillance en temps réel de différents tronçons d'un trajet à travers un segment de transport augmente la flexibilité et permet des options de possibilité de changement. Dans d'autres aspects, la flexibilité apportée par des demandes de transport généralisées et des itinéraires généralisés permet aux fournisseurs de services de transport d'améliorer significativement la mise en correspondance de la capacité à la demande des services de transport.
Patent EP-3412233-A2 (EP)
Inventor: MCMANUS JOSHUA
IPC: A61B17/88
Filed: 2018-06-04
Abstract: In one embodiment, an intramedullary nail insertion system has a handle, a coupler, and a securement member. The handle has a body that includes a distal body end, and a proximal body end that is spaced from the distal body end along a proximal direction. Further, the handle defines an aperture that extends from the distal body end to the proximal body end. The coupler includes a distal coupler end having a first fastener that fastens to an intramedullary nail, and includes a proximal coupler end having a second fastener sized to be received through the distal body end in the proximal direction into the aperture of the handle. The securement member has a third fastener that fastens to the second fastener of the coupler so as to capture the handle body between the securement member and the intramedullary nail. The system can be assembled using a two-handed operation.
Patent EP-3438578-A2 (EP)
Inventor: BENTO EDSON ISALTINO
IPC: F25D17/06
Filed: 2018-07-24
Abstract: A refrigerator (12) includes a housing subassembly (14) defining a generally enclosed volume (16), an air outlet (18) in fluid communication with the enclosed volume (16), and a divider unit (20) separating the enclosed volume (16) into first and second compartments (22, 24). The divider unit (20) includes a central wall (26) aligned with the air outlet (18) and exposing respective portions (28, 30) of the air outlet (18) to the first and second compartments (22, 24). A flap (32) is disposed within the air outlet (18) and is rotatable about an articulation axis (34) aligned with respect to the central wall (26) and with a body (36) of the flap (32) extending in an upstream direction (38) within the air outlet (18). A control element (40) is mounted external to the enclosed volume (16) and is operably coupled with the flap (32) to drive its rotation.
Patent EP-3492247-A2 (EP)
Title: Structural rework of cellular core panels
Inventor: EVENS MICHAEL W
IPC: B26B3/04
Filed: 2018-08-14
Abstract: Methods for reworking structures and reworked cellular core panels, reworked structures comprising the reworked cellular core panels, and guides and cutting apparatuses for reworking cellular acoustic panels and reworking cellular non-acoustic panels are disclosed. (Fig. 1A)
Patent EP-3486256-A2 (EP)
Inventor: WADIA JEHANGIR
IPC: G01N33/68
Filed: 2015-06-26
Abstract: The invention relates to antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau. The invention also relates to diagnostic, prophylactic and therapeutic methods using anti-tau antibodies.
Patent EP-3498451-A2 (EP)
Inventor: GELTINGER FLORIAN
IPC: B29C49/48
Filed: 2015-10-09
Abstract: Eine Vorrichtung (1) zum Umformen von Kunststoffvorformlingen zu Kunststoffbehältnissen, mit wenigstens einer Umformungsstation (4), welche eine Blasform aufweist, innerhalb derer die Kunststoffvorformlinge durch Beaufschlagung mit einem gasförmigen Medium expandierbar sind, wobei die Blasform ein Bodenteil (42) aufweist, welches lösbar an einem Träger (12) angeordnet ist, und mit einem ersten Befestigungsmechanismus (6), um das Bodenteil (42) an dem Träger (12) zu befestigen, und wobei die Blasform wenigstens ein Seitenteil (52a, 52b), aufweist, welches lösbar an einem Träger (46a, 46b) angeordnet ist und mit einem zweiten Befestigungsmechanismus (40), um das Seitenteil (52a, 52b) an dem Träger (46a, 46b) zu befestigen. Erfindungsgemäß ist der erste Befestigungsmechanismus (6) mittels eines fließfähigen Mediums betätigbar, um das Bodenteil (42) gegenüber dem Träger (12) zu entriegeln und der zweite Befestigungsmechanismus (40) ist mittels eines fließfähigen Mediums betätigbar, um das Seitenteil (52a, 52b) von dem Träger (46a, 46b) zu entriegeln und weiterhin ist eine Medienanschlusseinrichtung (20) vorgesehen, um das fließfähige Medium den Befestigungsmechanismen (6, 40) zuzuführen.
Patent EP-3571388-A2 (EP)
Inventor: GRANZIERA CYRIL
IPC: F02N11/08
Filed: 2018-01-19
Abstract: The invention relates mainly to a method for restarting a heat engine (11) of a motor vehicle via a starter-alternator (10) coupled to said heat engine (11) and comprising a control module (14), characterised in that, if the start of the heat engine (11) fails, the method comprises: - a step of suspending the torque generated by the alternator-starter (10) for a predetermined duration, and - a second step of activating the alternator-starter (10) to regenerate the starting torque of the heat engine (11) when the speed of rotation of the heat engine (11) exceeds a predetermined threshold while the engine (11) is in a rebound phase.
Patent EP-3585446-A2 (EP)
Inventor: BLAIR WILLIAM
IPC: A61K49/00
Filed: 2018-04-05
Abstract: Imaging marker embodiments that may be used for marking sites within a patient's body are discussed. Some imaging marker embodiments are particularly useful for imaging with ultrasound imaging modalities and some imaging marker embodiments may be suitable for imaging with multiple modes of imaging modalities. Method embodiments for making and using imaging markers are also discussed herein.
Patent EP-3691679-A2 (EP)
Inventor: LESBROS CYNTHIA
IPC: A61K39/12
Filed: 2018-10-05
Abstract: The present invention relates to the use of a vaccine composition comprising at least one feline calicivirus antigen and/or at least one feline leukemia virus antigen and/or at least one feline herpesvirus-1 antigen, for use in the control and/or the treatment and/or the prevention of a disease or disorder caused by an infection with a feline calicivirus and/or a feline leukemia virus and/or a feline herpesvirus-1 respectively, in a feline, wherein said vaccine composition is administered in one single administration to the feline.
Patent EP-3727459-A2 (EP)
Inventor: MÜLLER FABIAN
IPC: A61K47/55
Filed: 2018-12-18
Abstract: The present invention relates to conjugates comprising an immunotoxin linked to a therapeutic agent, wherein said immunotoxin comprises a binding domain fused to an adenosine diphosphate (ADP) ribosylating toxin, pharmaceutical compositions comprising said conjugates, and methods for the preparation of said immunotoxins.
Patent EP-3784281-A2 (EP)
Inventor: MIAO CAROL HSING
IPC: A61K39/395
Filed: 2019-04-26
Abstract: Methods, compositions, and systems for treating subject(s) in need of plasma Factor VIII, particularly a subject having preexisting anti-FVIII inhibitory antibodies, are provided. The methods involve administering to the subject a therapeutically effective amount of an inflammation suppressor, a therapeutically effective amount of a CD8+ T cell depleting agent, and a therapeutically effective amount of a composition comprising a lentiviral vector (LV) comprising an optimized FVIII expression cassette expressibly linked to a megakaryocyte-specific promoter. Such methods, compositions, and systems are useful to treat subjects with blood clotting disorder(s), such as hemophilia A.
Patent EP-3880325-A2 (EP)
Inventor: SOELBERG TINO
IPC: A63F13/218
Filed: 2019-11-15
Abstract: Un système qui incorpore la présente invention peut comprendre, par exemple, un processeur qui effectue des opérations comprenant la réception d'un profil d'actionnement comprenant un ou plusieurs seuils d'actionnement en réponse à une détection d'un événement de déclenchement pendant une session de jeu d'un jeu vidéo, la configuration du capteur selon le ou les seuils d'actionnement, la réception, en provenance du capteur, d'un signal indiquant une plage de dépression du bouton, la comparaison de la plage de dépression avec un ou plusieurs seuils d'actionnement du profil d'actionnement, et la génération d'un état d'actionnement lorsque la plage de dépression dépasse un seuil d'actionnement du ou des seuils d'actionnement. Des modes de réalisation supplémentaires sont décrits.
Patent EP-3870612-A2 (EP)
Inventor: DUNN MICHAEL
IPC: C07K16/28
Filed: 2019-10-18
Abstract: The present invention provides monoclonal antibodies that bind to the natriuretic peptide receptor 1 (NPR1) protein, and methods of use thereof. In various embodiments of the invention, the antibodies are fully human antibodies that bind to NPR1. In some embodiments, the antibodies of the invention are useful for activating NPR1 activity, thus providing a means of treating or preventing a disease, disorder or condition associated with NPR1 in humans.
Patent EP-3780674-A2 (EP)
Inventor: HAHN GENE BACK
IPC: H04W4/40
Filed: 2020-08-13
Abstract: An operation method of a first terminal in a communication system is provided. The method includes transmitting first SCI to a second terminal, the first SCI including one or more information elements among information indicating time resource(s) for sidelink communication, information indicating frequency resource(s) for the sidelink communication, information indicating a periodicity of physical resources for the sidelink communication, and information indicating an MCS for the sidelink communication. Second SCI is transmitted to the second terminal, the second SCI including information for an HARQ feedback operation and information indicating an NDI. The method further includes performing the sidelink communication with the second terminal based on the first SCI and the second SCI associated with the first SCI.
Patent EP-3918324-A2 (EP)
Inventor: ROESSLER CHRISTIAN
IPC: G01N33/72
Filed: 2020-01-27
Abstract: In some embodiments, the present disclosure is directed to coatings or thin films comprising a dye or stain embedded within a matrix, e.g. a polymer matrix.
Patent EP-3982860-A2 (EP)
Inventor: MURRAY JAMES
IPC: A61B17/88
Filed: 2020-06-03
Abstract: A system for delivering flowable biomaterial to an intervertebral disc space between adjacent vertebral bodies includes a delivery body defining a proximal end, a distal end spaced from the proximal end along a longitudinal direction, a cannulation extending from the proximal end to an opening adjacent the distal end, and a distal region including a tip that extends to the distal end. The distal region defines a maximum height at a location proximal of the distal end and measured along a second direction perpendicular to the longitudinal direction. The distal region is for indicating a distance between the adjacent vertebral bodies. The system includes a carrier having a longitudinaly elongate channel for carrying biomaterial and being insertable within the cannulation, as well as an advancement member configured for insertion within the cannulation to forcibly advance the biomaterial from the cannulation, through the opening, and into the disc space.
Patent EP-3976007-A2 (EP)
Inventor: SAHIN FIKRETTIN
IPC: A61P41/00
Filed: 2020-05-29
Abstract: The present invention relates to a glycerol and sodium pentaborate based formulation developed for preventing postoperative adhesions occurring between the manipulated tissues and organs. The objective of the present invention is to provide a formulation comprising a mixture of glycerol, which is one of the most abundant biomolecules in the human body, and sodium pentaborate, which is known to have positive effects on wound healing, with the purpose of preventing postoperative adhesions.
Patent EP-3986470-A2 (EP)
Inventor: QI JUN
IPC: A61K31/454
Filed: 2020-06-17
Abstract: Disclosed are bispecific compounds (degraders) that target EP300/CBP for degradation. Also disclosed are pharmaceutical compositions containing the degraders and methods of using the compounds to treat disease.
Patent EP-3955147-A2 (EP)
Inventor: LANTUH NICK
IPC: G06F21/50
Filed: 2021-08-05
Abstract: In some embodiments, a method can include identifying detection coverage of a set of adversarial techniques based on telemetry data and a detection instance of an environment. The method can further include determining a subset of detection coverage that has a metric value below a metric value threshold and among the detection coverage for the set of adversarial techniques. The method may further include identifying at least one detection instance associated with the subset of detection coverage. The method can further include presenting, via a graphical user interface, a representation of at least one of the subset of detection coverage or the at least one detection instance associated with the subset of detection coverage. The method can further include updating the subset of detection coverage based on the telemetry data, the detection instance, or the at least one detection instance to improve the metric value.
Patent EP-4175543-A2 (EP)
Inventor: HANSMANN HANS-ULLRICH
IPC: G01N27/18
Filed: 2021-06-28
Abstract: The present invention relates to a sensor arrangement (10) for a medical apparatus (12), having a sensor unit (11) for determining a carbon dioxide concentration in measurement gas, a branch line (14) for diverting the measurement gas from a main line (15) of the medical apparatus (12) and for conveying the diverted measurement gas to the sensor unit (11), and at least one HME filter (16, 17) for filtering the diverted measurement gas. The invention further relates to a medical apparatus (12) having a sensor arrangement (10) according to the invention, an exhalation valve (25) for a medical apparatus (12) according to the invention, and a method for determining a carbon dioxide concentration.
Patent EP-4229809-A2 (EP)
Inventor: TAHERZADEH BOROUJENI MAHMOUD
IPC: H04L5/00
Filed: 2021-10-13
Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a user equipment (UE) may receive, from a base station, a first configuration for a physical uplink control channel (PUCCH) resource set, the first configuration associated with a first configured number of symbols for a PUCCH. The UE may receive, from the base station, an indication of a number of symbols to be used for transmitting the PUCCH, the indicated number of symbols being different from the first configured number of symbols. The UE may transmit the PUCCH using the indicated number of symbols. Numerous other aspects are provided.
Patent EP-4178984-A2 (EP)
Title: Novel anti-pd1 antibodies for inhibiting t-cell activity
Inventor: ALT FREDERICK W
IPC: C07K16/28
Filed: 2021-07-13
Abstract: The technology described herein is directed to novel anti-PD1 antibody reagents (e.g., antibodies, antigen-binding fragments thereof, and/or chimeric antigen receptors). Also decribed herein are antibody-drug conjugates or kits comprising the disclosed antibody reagents, as well as methods of treating an autoimmune or auto-inflammatory disorder by administering the disclosed antibody reagents.
Patent EP-4271769-A2 (EP)
Inventor: ATKINS MARTIN
IPC: C10B57/10
Filed: 2021-12-31
Abstract: The present invention relates to a process and system for forming a bio-derived gasoline fuel from a biomass feedstock, and the bio-derived gasoline fuel formed therefrom. The present invention also relates to a process and system for forming a bio-derived gasoline fuel from a bio-derived hydrocarbon feedstock, and the bio-derived gasoline fuel formed therefrom.
Patent EP-4035675-A2 (EP)
Inventor: SCHUSTER HEIKO
IPC: C07K14/705
Filed: 2018-01-26
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Patent EP-4314296-A2 (EP)
Inventor: SOUNDARAPANDIAN MANGALA MEENAKSHI
IPC: C12N15/113
Filed: 2022-03-28
Abstract: L'invention concerne des agents d'acide ribonucléique double brin (ARNidb) et des compositions ciblant un gène de huntingtine (HTT) ainsi que des procédés d'inhibition de l'expression d'un gène HTT et des procédés de traitement de sujets ayant une maladie ou un trouble associé à HTT, par exemple, la maladie de Huntington, à l'aide de tels agents et compositions d'ARNidb.
Patent EP-4235315-A2 (EP)
Inventor: MORIOKA MASANARI
IPC: G03G21/18
Filed: 2020-03-17
Abstract: [Problem to be solved] To further develop conventional technique. 
     [Solution] a cartridge includes a casing, a photosensitive drum and a coupling. the coupling includes a driving force receiving portion for receiving a driving force by engagement with a driving force application member, a braking force receiving portion for receiving in braking force by engagement with a braking force application member, and a guide for moving the braking force application member relative to the driving force application member.
Patent EP-4269289-A2 (EP)
Inventor: SANGIACOMO PAOLA
IPC: B65G15/38
Filed: 2018-09-18
Abstract: The invention concerns a conveyor (1) for a continuous baking oven (10), wherein the conveyor (1) is of the closed-ring type and comprises an outer surface (2) and an inner surface (3), and wherein the conveyor (1) is equipped with a plurality of seats (4) intended to receive a food product to be cooked, wherein the seats of the plurality of seats have respective mouths (5) essentially open at the level of the outer surface (2) of the conveyor.
Patent EP-4277181-A2 (EP)
Inventor: YE CHUNXUAN
IPC: H04L1/18
Filed: 2021-04-06
Abstract: Determining priority of a simultaneous sidelink (SL) transmission and uplink (UL) transmission of a user equipment (UE) within a 5G New Radio (NR) network may comprise processing an SL control information (SCI) corresponding to at least one of a SL hybrid automatic repeat request (HARQ) or an SL schedule request (SR) included in a UL transmission to be sent by a UE to thereby determine a priority value associated with the at least one SL HARQ or SL SR. An SCI of an SL transmission to be sent by the UE simultaneously with the UL transmission may be processed to thereby determine a priority value associated with the SL transmission. The priority value of the at least one SL HARQ or SL SR may be compared to the priority value of the SL transmission. Transmissions may then be prioritized based on the comparison of priority values.